Glycemic Variation in Patients of Acute Coronary Syndrome with Hyperglycaemia and its Relationship with Oxidative Stress: A Pilot Study
Abstract
Aim: The aim of this study was to establish the relationship between the glycemic variation in patients of Acute Coronary Syndrome (ACS) with hyperglycemia, oxidative stress and pre-discharge assessment of glycemic status by Oral Glucose Tolerance Test (OGTT).
Materials and Method: Nineteen non-diabetic patients who presented with acute coronary syndrome with random blood sugar ≥200 mg/dl were recruited and glycemic variation was measured using CGMS followed by measurement of 8-isoprostanes PG-2alpha as a marker of oxidative stress, and pre-discharge OGTT was done to know the glycemic status at the time of discharge.
Result: Mean MAGE (A parameter of glycemic variation) was 106.92±22.66 and mean 8-isoprostanes level was 206.05±179.57. There was no relationship between these two values. On doing OGTT, out of 19 non diabetic patients 11 turned out to be frank diabetic and 8 were having impaired glucose tolerance after OGTT, none were euglycemic.
Conclusion: The study highlighted the issue of hyperglycaemia in ACS patients and their abnormal glucose tolerance in the short term, most of them turning to be frankly diabetic and being totally asymptomatic till the time of index event, although no correlation was found between glycemic variability and oxidative stress.
How to cite this article:
Kumar K, Kumari P, Avasthi R, Ahmed RS, Jaid M, Kumar R. Glycemic Variation in Patients of Acute Coronary Syndrome with Hyperglycaemia and its Relationship with Oxidative Stress: A Pilot Study. J Adv Res Med 2020; 7(3): 16-19.
DOI: https://doi.org/10.24321/2349.7181.202015
References
Deedwania P, Kosiborod M, Barrett E et al. Hyperglycemia and Acute Coronary Syndrome. Anesthesiology 2008; 109(1): 14-24.
Kota S, Modi K, Satya Krishna S. Glycemic variability: Clinical implications. Indian J Endocrinol Metab 2013;
(4): 611.
Wahab NN, Cowden EA, Pearce NJ et al. Is blood glucose an independent predictor of mortality in acute
myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40(10): 1748-54.
Norhammar A, Tenerz Ã…, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction
and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359(9324): 2140-4.
Service FJ, Molnar GD, Rosevear JW et al. Mean amplitude of glycemic excursions, a measure of diabetic
instability. Diabetes 1970; 19(9): 644-55.
Hill NR, Oliver NS, Choudhary P et al. Normal reference range for mean tissue glucose and glycemic variability
derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
Diabetes Technol Ther 2011; 13(9): 921-8.
Szuldrzynski K, Zalewski J, Machnik A et al. Elevated levels of 8-iso-prostaglandin F2alpha in acute coronary
syndromes are associated with systemic and local platelet activation. Pol Arch Med Wewn 2010; 120(1-
: 19-24.
Stojiljkovic MP, Lopes HF, Zhang D et al. Increasing plasma fatty acids elevates F2-isoprostanes in humans:
Implications for the cardiovascular risk factor cluster. J Hypertens 2002; 20(6): 1215-21.
Morrow JD, Frei B, Longmire AW et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers - smoking as a cause of oxidative damage. N Engl J Med 1995; 332(18): 1198-203.
Davi G, Alessandrini P, Mezzetti A et al. In vivo formation of 8-epi-prostaglandin F(2α) is increased
in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997; 17(11): 3230-5.
Keaney JF, Larson MG, Vasan RS et al. Obesity and systemic oxidative stress: Clinical correlates of oxidative
stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003; 23(3): 434-9.
